Michael T. Rudd
31Patents
4h-index
86Co-inventors
62Inventor score
Filing activity: Apr 28, 2006 → Aug 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7470664B2 | HCV NS3 protease inhibitors | Human Necessities | 49 | Active |
| US8216999B2 | HCV NS3 protease inhibitors | Human Necessities | 18 | Active |
| US10512638B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 8 | Active |
| US7879797B2 | HCV NS3 protease inhibitors | Chemistry; Metallurgy | 6 | Active |
| US9278960B2 | Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use | Chemistry; Metallurgy | 4 | Active |
| US8461107B2 | HCV NS3 protease inhibitors | Human Necessities | 4 | Active |
| US9636337B2 | Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use | Chemistry; Metallurgy | 2 | Active |
| US10933056B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 2 | Active |
| US9663506B2 | Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use | Chemistry; Metallurgy | 2 | Active |
| US8377874B2 | HCV NS3 protease inhibitors | Human Necessities | 1 | Active |
| US11098029B2 | 5-alkyl pyrrolidine orexin receptor agonists | Chemistry; Metallurgy | 1 | Active |
| US8278322B2 | HCV NS3 protease inhibitors | Human Necessities | 1 | Active |
| US8309540B2 | HCV NS3 protease inhibitors | Human Necessities | 1 | Active |
| US10239849B2 | Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their use | Chemistry; Metallurgy | 1 | Active |
| US9102673B2 | Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11149036B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 1 | Active |
| US10981902B2 | 5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 0 | Active |
| US10894775B2 | Piperidine derivatives as liver X receptor beta agonists, compositions, and their use | Chemistry; Metallurgy | 0 | Active |
| US11339156B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 0 | Active |
| US8927569B2 | Macrocyclic compounds as antiviral agents | Chemistry; Metallurgy | 0 | Active |
| US8828930B2 | Hepatitis C virus NS3 protease inhibitors | Human Necessities | 0 | Active |
| US9738661B2 | HCV NS3 protease inhibitors | Human Necessities | 0 | Active |
| US10961215B2 | N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use | Chemistry; Metallurgy | 0 | Active |
| US8591878B2 | Therapeutic compounds | Chemistry; Metallurgy | 0 | Active |
| US9328138B2 | HCV NS3 protease inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.